Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Heat Shock Proteins: Therapeutic Drug Targets for Chronic Neurodegeneration?

Author(s): M. U. Sajjad, B. Samson and A. Wyttenbach

Volume 11, Issue 2, 2010

Page: [198 - 215] Pages: 18

DOI: 10.2174/138920110790909641

Price: $65

Abstract

Intra- and extracellular protein misfolding and aggregation is likely to contribute to a number of age-related central nervous system diseases (“proteinopathies”). Therefore, molecular chaperones, such as heat shock proteins (HSPs), that regulate protein folding, misfolding and adaption to cellular stress are emerging as therapeutic targets. Here we review the current knowledge of HSP-modulating drugs and discuss the opportunities and difficulties of their therapeutic use to treat proteinopathies such as Alzheimers- and Parkinsons disease, the polyglutamine- and prion disorders and Amyotrophic Lateral Sclerosis.

Keywords: Protein misfolding, neuroprotection, proteinopathies, molecular chaperones


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy